Elmar snow

from Wikipedia, the free encyclopedia

Elmar J. Schnee (* 1959 ) is a Swiss manager.

Elmar Snow (2008)

Career

After school, Schnee trained as a marketing manager at the Swiss Institute for Business Administration in Zurich . In 1980 he first worked in a Swiss advertising agency and then took on various functions in marketing and sales in the consumer goods industry. In 1988 he became Marketing & Sales Director of the Swiss subsidiary of Fisons Pharmaceuticals . Four years later he became head of global CNS and cardiovascular marketing at the company's UK headquarters. In 1996, Schnee moved to the US company Migliara / Kapan Associates, where he became Vice President for Consulting. Just one year later, he became Director of the Thrombosis Business Unit at Sanofi-Synthélabo . In 1999, Schnee moved to UCB Pharma in Brussels. There he was initially Group Director for worldwide marketing, licensing and strategy; then Managing Director of UCB Farchim SA in Switzerland. In May 2003, he came as a director for Merck owned subsidiary Merck Santé SAS to Lyon in France. In January 2004 he also took on global operational responsibility for the Ethicals division ( original prescription drugs ). In 2005 he was appointed head of the Ethicals division. On November 22, 2005, Schnee became Head of the Pharmaceuticals Division of Merck KGaA, and in 2006 a full member of the Executive Board of Merck KGaA and personally liable partner. In January 2007 he became CEO of Merck Serono, a subsidiary of Merck KGaA. On December 13, 2010, Merck KGaA announced that Schnee was leaving the company on December 31, 2010 “for personal reasons”. Stefan Oschmann, who previously worked at MSD Sharp & Dohme , was appointed as his successor . Schnee was criticized for setbacks in the pharmaceuticals sector. In particular , he was blamed for the approval of cladribine , which had been rejected by the FDA and the European Medicines Agency .

Schnee is a member of the supervisory board of the Australian company ChemGenex Pharmaceuticals Ltd.

literature

Web links

Individual evidence

  1. ↑ Elmar Schnee becomes the new CEO of Merck Serono. In : wirtschaft.ch of January 8, 2007
  2. ↑ Change in the management of Merck. (PDF; 26 kB) Press release from Merck KGaA dated December 13, 2010
  3. ↑ KM Smolka and M. Scheele: Merck replaces the pharmaceutical board. ( Memento of December 14, 2010 in the Internet Archive ) In: Financial Times Deutschland of December 12, 2010
personal data
SURNAME Snow, Elmar
ALTERNATIVE NAMES Schnee, Elmar J.
BRIEF DESCRIPTION Swiss manager
DATE OF BIRTH 1959